Repligen (RGEN) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

RGEN is expected to report earnings to rise 1.64% to 33 cents per share on October 29

Q3'24

Est.

$0.34

Q2'24

Est.

$0.33

Q1'24

Missed

by $0.02

Q4'23

Est.

$0.33

Q3'23

Beat

by $0.07

The last earnings report on July 30 showed earnings per share of 33 cents, meeting the estimate of 33 cents. With 560.57K shares outstanding, the current market capitalization sits at 10.26B.

View a ticker or compare two or three

Compare

RGEN

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For RGEN
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for RGEN (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a developer of biologic drugs

Industry MedicalSpecialties

Profile

Fundamentals

Details

Industry

Biotechnology

Address

41 Seyon Street

Phone

+1 781 250-0111

Employees

1783

Web

https://www.repligen.com